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ABSTRACT 
 
Nephrotic syndrome (NS) is an autoimmune disease that correlates to the imbalance of regulatory T cells (TReg). 
This study was aimed to investigate the effect of vitamin D as adjuvant therapy of TReg population in pediatric 
nephrotic syndrome. This study was designed randomized clinical trial, double blind, with pre- and post-test control 
groups involving 15 subjects newly diagnosed with NS. Subjects were divided into 2 groups, namely K1 for group 
treated with prednisone+vitamin D and K2 group for prednisone treatment only. The population of TReg in periph-
eral blood mononuclear cells (PBMC) was analyzed using flowcytometry. Vitamin D serum level was measured 
through ELISA method. Results showed that there was a significant elevation of TReg (independent t-test, p = 0.010) 
in K1 group, which was higher than in K2 group. The Pearson test in the K1 group showed that vitamin D level 
was positively correlated with TReg (p = 0.039, r = 0.779). 
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INTRODUCTION 
Idiopathic nephrotic syndrome is a glomerular dis-
ease characterized by several clinical manifestations such 
as severe proteinuria, hypoalbuminemia, hyperlipide-
mia, and edema [1, 2]. The prevalence of nephrotic syn-
drome stands at 12 – 16 cases per 100,000 children, 
which is mostly found at the age of 2 – 5 years old. In 
Indonesia, there were 6 cases found in every 100,000 
children below 14 years old per year in children, which 
is dominated by male (male: female ratio = 2 : 1) [3].  
Pathogenesis of nephrotic syndrome is based on the 
immunological aberration, characterized by abundant 
circulating factor [4] and immuno-regulatory imbalance 
[5]. Conversely, regulatory T-cells (TReg) is an important 
tolerogenic T-cell possessing protective effect on podo-
cyte destruction [6, 7]. Vitamin D has been known as 
immunomodulator that able to induce TReg differentia-
tion as it has pleiotropic effects [8, 9]. Therefore, this 
study was aimed to investigate the effect of vitamin D as 
adjuvant therapy to the TReg population in pediatric ne-
phrotic syndrome.  
 
MATERIALS AND METHODS 
This study was conducted at Biomedical Laboratory,  
Faculty of Medicine, Brawijaya University. The duration 
of the study ranged between February until July 2015. 
 
Study Design 
This study was designed as a randomized clinical 
trial (RCT) double blind, with pre-and post-test control 
group. There were 2 groups namely K1 (prednisone and 
vitamin D3) and K2 (prednisone only). TReg population 
and vitamin D levels were measured before and after 
treatment. Treatment for K1 were prednisone 2 mg/kg 
body weight/day (maximal dose 80 mg/day) and vitamin 
D3 oral preparation (D-Vit, PT. Gracia PharmindoTM) 
2000 IU/day for 4 weeks. Treatment for K2 was predni-
sone 2 mg/kg body weight/day (maximal dose 80 
mg/day) for 4 weeks according to ISKDC protocol. All 
the procedures and treatments of this study had been 
approved by the Ethical Committee Faculty of Medicine, 
University of Brawijaya, Malang No. 314/EC/KEPK-
S2/05/2015. 
 
Subjects 
There were 15 subjects included in this study (7 sub-
jects in K1; 8 subjects in K2). Subjects were taken from 
the Pediatric Nephrology Outpatient Care and Pediatric 
 Yunika Nurtyas, 2018 
 
 
 JTLS | J. Trop. Life. Science 44 Volume 8 | Number 1 | January | 2018 
Ward, Dr. Saiful Anwar General Hospital, Malang dur-
ing February – July 2015. The inclusion criteria for this 
study were newly diagnosed nephrotic syndrome 
patients aged 1 – 14 years old whose parents allowed 
them to participate in this study (informed consent). 
Meanwhile, the exclusion criteria for this study were sec-
ondary nephrotic syndrome, congenital nephrotic syn-
drome, relapse nephrotic syndrome, and steroid depend-
ent nephrotic syndrome. 
 
Isolation of Peripheral Blood Mononuclear Cells 
(PBMC) 
Blood samples in EDTA vacutainer were homoge-
nized and added with PBS at a ratio of 1 : 1. The blood 
sample-PBS mixture was transferred slowly into falcon 
tube walls filled with Ficoll-Hipaque d = 1.077 g/dL (1 : 
1). This mixture was centrifuged at 1,500 rpm at room 
temperature for 30 minutes which resulted in the for-
mation of 4 layers namely plasma, PBMC, Ficoll-
Hipaque, and erythrocyte. The PBMC ring was slowly 
transferred into 15mL centrifuge bottle. It was washed 
with 10mL PBS and centrifuged at 1200 rpm, at room 
temperature for 10 minutes. The supernatant was re-
moved, washed using PBS, and centrifuged again at 
1,200 rpm at room temperature for 10 minutes. After 
the second process of washing and centrifugation, 
PBMC will be formed as pellet at the bottom of centri-
fuge bottle. 
 
Measurement of regulatory T-cell population 
The population of TReg was measured trough 
flowcytometry method. Antibodies that were used phy-
coerythrin (PE) anti-human FOXP3, FITC anti-human 
CD4, and PE/Cy5 anti-human CD25 (eBioscience, San 
Diego, CA). PBMC was suspended at certain density (2 
× 106 cells/mL) in culture medium (RPMI equipped with 
penicillin 100 U/mL, streptomy-cin 100 µg/mL, gluta-
mine 2 mM, 10% calf fetal serum). The cell suspension 
was transferred into 24 wells then was stimulated with 
phorbol myristate acetate (PMA) 50 ng/mL and iono-
mycin 1 µM for 4 hours in monensin 500 ng/mL (Alexis 
Biochemical, San Diego, CA). The incubator was set at 
temperature of 37°C and air pressure of 5% CO2. After 
4 hours, the cell culture was transferred into sterile tubes 
and centrifuged at 1,500 rpm for 15 minutes. 
T-cell lymphocyte was transferred into new tubes, 
washed with phosphate-buffered saline (PBS), and then 
incubated with fluorescein isothiocyanate (FITC) anti-
human CD4 and PE CD25 at 4°C for 30 minutes. After 
incubation, speciments were stained with PE anti-hu-
man Foxp3. Specimens were transferred into cuvette 
ready for flowcytometry analysis. The population of TReg 
was analyzed with BD Cell Quest Pro.  
 
Measurements of vitamin D level 
Vitamin D level was measured through ELISA 
method as previously described. Briefly 200 µL pre-di-
luted serum samples were added into each well then it 
incubated for 2 hours at 25°C. After being washed, 100 
µL enzyme conjugate was added into the tubes and in-
cubated for 30 minutes at room temperature. Following 
this, 100 µL chromogen/substrates solution was added 
and incubated for 15 minutes at room temperature in 
dark room. Finally, 100 µL stop solution was added to 
each well. After 30 minutes, specimens were ready for 
analysis using ELISA reader at 650 nm.  
 
Statistical analysis 
Data distribution and homogeneity were statistically  
Table 1. Subject Characteristics 
Characteristics 
Combination 
Prednison+vitamin D (n = 7) 
Prednisone only 
(n = 8) 
Age (years) 
1 – ≤ 5 6 0 
> 5 - < 10  1 7 
≥ 10 – 14  0 1 
Sex 
Male 5 7 
Female 2 1 
Vitamin D Status 
Normal 0 6 
Insufficiency 6 2 
Deficiency 1 0 
Nutritional Status 
Good 5 6 
Undernutrition 2 2 
Note: SSNS (steroid sensitive nephrotic syndrome), SRNS (steroid resistant nephrotic syndrome) 
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analyzed. Moreover, statistical differences of TReg and vi-
tamin D levels between groups were analyzed by 
independent t-test. The differences of TReg, Th17, and 
vitamin D before and after treatment were analyzed by 
paired t-test. The correlation of TReg and vitamin D level 
was analyzed with the Pearson correlation test. Data was 
analyzed at 95% confidence interval (α = 0.05) using 
SPSS version 17.0. for Windows. 
 
RESULTS AND DISCUSSION 
Subject and baseline characteristics 
Subject characteristics such as age, sex, vitamin D 
status, outcomes (steroid sensitive or resistant), and nu-
tritional status were shown in Table 1. Morover the 
clinical outcome of subjects were shown in Table 2. 
Remission before 4 weeks and remission after 4 weeks 
were found in both groups that earlier was also found in 
K1. Most of the subjects were diagnosed with steroid 
sensitive nephrotic syndrome (SSNS), there was only 
one patient did not get remission and is classified as ster-
oid resistant nephrotic syndrome (SRNS). 
Based on the age factor, subjects were mostly from 
kids aged under 10 years old. The subjects were domina-
ted by male or 12 boys from 15 subjects. This finding 
was also in accordance with previous studies and has 
been considered to be correlated with abnormal T cell 
clones in male thymus gland [10]. Based on nutritional 
status, it is revealed that most subjects had good nutri-
tional status. However, it is important to evaluate nutri-
tional status of children with nephrotic from syndrome 
because they are at high risk of suffering from malnour-
ishment. 
Vitamin D level status in nephrotic syndrome pa-
tients (9 of 15) was low. This result was in accordance 
with previous study conducted in the General Hospital 
Dr. Cipto Mangunkusumo that 22 of 26 nephrotic pa-
tients had low vitamin D levels (10 insufficiency, 16 de-
ficiency) [11]. Loss of vitamin D-bounded protein 
through urine had been considered as etiologic factor for 
low plasma concentration in nephrotic patients [12]. 
Low vitamin D levels cause hyper-reactivity o dendritic 
cell, T cell, B cell, TReg suppression, and pro-inflamma-
tory cytokines elevation [13] that would lead to ne-
phrotic syndrome. Several factors affect 25(OH)D level 
such as age, race, season, and milk consumption [14].  
 
Regulatory T cell population 
The results demonstrated that there was no signifi-
cant difference in the population of TReg in K1 and K2 
(independent t-test, p = 0.97 pretest) before treatment.  
Table 2. Clinical outcome 
Outcome 
Combination 
Prednisone+ vitamin 
D (n=7) 
Prednisone 
only (n=8) 
Classification   
SNSS 6 8 
SNRS 1 0 
Remission   
Early responder 5 4 
Late responder 1 4 
Resistance 1 0 
 
Figure 1. Treg percentage before treatment (pre-test) and after 
treatment (post-test) 
 
Figure 2. Vitamin D Level before treatment (pre-test) and after 
treatment (post-test) 
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However, the differences were found significantly after 
treatment (independent t-test, p = 0.03 post test). Fur-
thermore, the elevation of the TReg population in K1 and 
K2 (before and after treatment, independent t-test, p = 
0.01) were significantly different. Figure 1 shows the 
TReg percentage before treatment, after treatment, and its 
enhancement after treatment. Furthermore, the enhan-
cement of TReg percentage was significantly different in 
both groups (paired t-test, K1 p = 0.00, K2 p = 0.00). 
 
Vitamin D level and Treg population 
The vitamin D level was found higher in K1 than 
K2 (before and after treatment, independent t-test, p = 
0.00). Figure 2 shows vitamin D levels before treatment, 
after treatment, and its elevation after treatment. Fur-
thermore, the elevation of vitamin D level was signifi-
cantly different in both groups (paired t-test, K1 p = 
0.00, K2 p = 0.00). 
The elevation of TReg population in prednisone and 
vitamin D treated group was higher than in prednisone 
only treated group. Reduction of TReg population and its 
dysfunction in nephrotic syndrome would lead to dis-
ability to suppress effector T cells [15] that is associated 
to proteinuria [16, 17]. TReg also acts as anti-inflamma-
tory T cells through secretion of several anti-inflamma-
tory cytokines such as IL-10 and TGF-β [18].  
Vitamin D administration could induce and stimu-
late TReg directly through antigen presenting cells or 
dendritic cells also indirectly through endocrine or in-
tracrinal conversion of 25(OH)D becoming 1,25(OH)2 
D3 [18]. Furthermore, vitamin D administration was 
correlated with elevation of TReg Foxp3+ population [9, 
19]. Several mechanisms focused on how vitamin D af-
fects TReg have been studied. Administration of 1,25(O 
H)2D3 could enhance STAT5 phosphorylation in 
Foxp3+ cells via TGF-β and IL-2 that lead to TReg differ-
entiation [20, 21]. Conversely, low vitamin D levels 
would lead to IL-6 upregulation instead of TGF-β down-
regulation causing Th17 differentiation [21]. 
Glucocorticoid had been known as one of anti-in-
flamation drugs that induces T cell apoptosis, T cell en-
ergy, and suppress T cell function [22]. Furthermore, 
glucocorticoid could induce IL-10 upregulation resulted 
in immature dendritic cells or macrophage thus induc-
ing differentiation of TReg/suppressor T cells [22]. Adju-
vant therapy with vitamin D3 could induce immuno-
supressive effects of TReg through upregulation of Foxp3 
and IL-10 [23, 24, 25].  
 
CONCLUSION 
CONCLUSION 
In conclusion, there was significant elevation of TReg  
population in the prednisone and vitamin D treated 
group than in prednisone only treated group. However, 
the vitamin D level was positively correlated with TReg 
population. 
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